OCUL OCULAR THERAPEUTIX, INC
Nasdaq · SEC CIK 1393434 · EDGAR
- Bought, last 12 months
- $461.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $3.42M 28 sales by 8 insiders
- Filings on record
- 160 since 2021-08-24, latest 2026-09-02 16:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dugel Pravin | See Remarks, Dir | — | $1.94M |
| LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| Saroj Namrata | Chief Business Off | — | $277.8K |
| Heier Jeffrey S. | CSO | — | $243.3K |
| Kaiser Peter | Chief Development Off | — | $222.9K |
| Waheed Nadia | Chief Medical Off | — | $220.9K |
| Notman Donald | See Remarks | — | $216.1K |
| Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| Anderman Todd | CLO | — | $137.4K |
| Robinson David Wayne | Gbl CCO | — | — |
Transactions 166
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 16:01 | 2026-08-31 | OCUL | Notman Donald | COO | S - Sale | $10.24 | -1,099 | 366.5K | -0.3% | -$11.3K | |
| T | 2026-08-26 17:59 | 2026-08-24 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $10.77 | -3,035 | 264.4K | -1% | -$32.7K |
| T | 2026-08-26 17:58 | 2026-08-24 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $10.78 | -1,897 | 326.9K | -0.6% | -$20.4K |
| T | 2026-08-26 17:57 | 2026-08-24 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $10.78 | -3,296 | 318.3K | -1% | -$35.5K |
| T | 2026-08-26 17:56 | 2026-08-24 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $10.77 | -21.6K | 2.53M | -0.8% | -$233.2K |
| MTI | 2026-08-26 17:56 | 2026-08-25 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | 0 | 744.9K | New | $0 |
| 2026-06-18 16:01 | 2026-06-16 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -50.1K | 2.55M | -2% | $0 | |
| I | 2026-06-18 16:01 | 2026-06-16 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +50.1K | 50.1K | New | $0 |
| D | 2026-06-12 17:23 | 2026-06-10 | OCUL | Warden Charles M | Dir | A - Grant | $0.00 | +14.0K | 100.5K | +16% | $0 |
| D | 2026-06-12 17:22 | 2026-06-10 | OCUL | Graves Adrienne L | Dir | A - Grant | $0.00 | +14.0K | 64.0K | +28% | $0 |
| D | 2026-06-12 17:22 | 2026-06-10 | OCUL | Robins Jason Shand | CFO | A - Grant | $0.00 | +15.4K | 68.1K | +29% | $0 |
| D | 2026-06-12 17:21 | 2026-06-10 | OCUL | Hong Seung Suh | Dir | A - Grant | $0.00 | +14.0K | 60.9K | +30% | $0 |
| D | 2026-06-12 17:20 | 2026-06-10 | OCUL | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +14.0K | 260.9K | +6% | $0 |
| D | 2026-06-12 17:19 | 2026-06-10 | OCUL | RAINES MERILEE | Dir | A - Grant | $0.00 | +14.0K | 60.9K | +30% | $0 |
| D | 2026-06-12 17:19 | 2026-06-10 | OCUL | Williams Leslie J. | Dir | A - Grant | $0.00 | +14.0K | 65.4K | +27% | $0 |
| T | 2026-06-05 16:01 | 2026-06-03 | OCUL | Waheed Nadia | Chief Medical Off | S - Sale | $8.27 | -14.8K | 300.1K | -5% | -$122.6K |
| T | 2026-05-28 16:08 | 2026-05-26 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $8.20 | -21.2K | 2.60M | -0.8% | -$173.5K |
| MTI | 2026-05-28 16:08 | 2026-05-28 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | 0 | 694.8K | New | $0 |
| T | 2026-05-28 16:07 | 2026-05-26 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $8.20 | -2,967 | 266.1K | -1% | -$24.3K |
| T | 2026-05-28 16:06 | 2026-05-26 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $8.20 | -3,018 | 320.4K | -0.9% | -$24.7K |
| T | 2026-05-28 16:05 | 2026-05-26 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $8.20 | -1,858 | 328.8K | -0.6% | -$15.2K |
| 2026-04-13 17:15 | 2026-04-09 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -394.7K | 2.62M | -13% | $0 | |
| I | 2026-04-13 17:15 | 2026-04-09 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +394.7K | 394.7K | New | $0 |
| 2026-02-25 | 2026-02-23 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $8.28 | -3,057 | 323.4K | -0.9% | -$25.3K | |
| 2026-02-25 | 2026-02-23 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $8.28 | -20.1K | 3.01M | -0.7% | -$166.1K | |
| 2026-02-25 | 2026-02-23 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $8.28 | -1,759 | 330.7K | -0.5% | -$14.6K | |
| 2026-02-25 | 2026-02-23 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $8.28 | -2,810 | 269.1K | -1% | -$23.3K | |
| 2026-02-24 | 2026-02-20 | OCUL | LINDSTROM RICHARD L MD | Dir | P - Purchase | $7.66 | +60.2K | 246.9K | +32% | +$461.4K | |
| 2026-02-24 | 2026-02-20 | OCUL | Waheed Nadia | Chief Medical Off | S - Sale | $7.74 | -3,510 | 314.9K | -1% | -$27.2K | |
| 2026-02-17 | 2026-02-12 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $9.04 | -124.9K | 3.03M | -4% | -$1.13M | |
| 2026-02-17 | 2026-02-12 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $9.04 | -10.3K | 332.4K | -3% | -$93.5K | |
| 2026-02-17 | 2026-02-12 | OCUL | Waheed Nadia | Chief Medical Off | S - Sale | $9.04 | -7,863 | 318.4K | -2% | -$71.1K | |
| 2026-02-17 | 2026-02-12 | OCUL | Notman Donald | COO | S - Sale | $9.04 | -11.4K | 366.4K | -3% | -$103.5K | |
| M | 2026-02-04 | 2026-02-02+ | OCUL | Notman Donald | COO | S - Sale | $8.82 | -11.5K | 383.8K | -3% | -$101.4K |
| D | 2026-01-26 | 2026-01-21 | OCUL | Robinson David Wayne | Gbl CCO | A - Grant | $0.00 | +136.0K | 136.0K | New | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Meyers Steve Lawrence | Chief Commercial Off | A - Grant | $0.00 | +64.9K | 217.6K | +42% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Notman Donald | See Remarks | A - Grant | $0.00 | +79.1K | 389.3K | +26% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +64.9K | 342.8K | +23% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Kaiser Peter | Chief Development Off | A - Grant | $0.00 | +79.1K | 271.9K | +41% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Heier Jeffrey S. | CSO | A - Grant | $0.00 | +79.1K | 326.4K | +32% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Anderman Todd | CLO | A - Grant | $0.00 | +64.9K | 152.5K | +74% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Waheed Nadia | Chief Medical Off | A - Grant | $0.00 | +79.1K | 326.3K | +32% | $0 |
| D | 2026-01-06 | 2026-01-02 | OCUL | Saroj Namrata | Chief Business Off | A - Grant | $0.00 | +79.1K | 254.6K | +45% | $0 |
| 2025-11-26 | 2025-11-24 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $12.02 | -3,007 | 191.4K | -2% | -$36.1K | |
| MI | 2025-11-26 | 2025-11-26 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | 0 | 0 | New | $0 |
| 2025-11-26 | 2025-11-24 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $12.04 | -19.5K | 3.16M | -0.6% | -$235.1K | |
| 2025-11-26 | 2025-11-24 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $12.04 | -3,469 | 245.9K | -1% | -$41.8K | |
| 2025-11-26 | 2025-11-24 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $12.04 | -1,878 | 277.9K | -0.7% | -$22.6K | |
| 2025-11-07 | 2025-11-05 | OCUL | Saroj Namrata | Chief Business Off | S - Sale | $10.74 | -25.9K | 174.1K | -13% | -$277.8K | |
| 2025-10-10 | 2025-10-08 | OCUL | Anderman Todd | CLO | S - Sale | $12.34 | -11.1K | 87.6K | -11% | -$137.4K | |
| 2025-10-06 | 2025-10-02 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $11.03 | -9,653 | 194.4K | -5% | -$106.5K | |
| 2025-10-06 | 2025-10-02 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $11.04 | -10.5K | 249.4K | -4% | -$115.9K | |
| 2025-09-11 | 2025-09-09 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -49.8K | 3.18M | -2% | $0 | |
| I | 2025-09-11 | 2025-09-09 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +49.8K | 49.8K | New | $0 |
| 2025-09-04 | 2025-09-02 | OCUL | Notman Donald | See Remarks | S - Sale | $12.43 | -1,066 | 308.8K | -0.3% | -$13.3K | |
| 2025-08-27 | 2025-08-25 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $12.04 | -1,885 | 279.7K | -0.7% | -$22.7K | |
| 2025-08-27 | 2025-08-25 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $12.04 | -3,063 | 259.9K | -1% | -$36.9K | |
| 2025-08-27 | 2025-08-25 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $12.04 | -3,011 | 204.1K | -1% | -$36.3K | |
| 2025-08-27 | 2025-08-25 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $12.04 | -21.5K | 3.23M | -0.7% | -$258.8K | |
| D | 2025-08-14 | 2025-08-12 | OCUL | Waheed Nadia | Chief Medical Off | A - Grant | $0.00 | +40.4K | 247.2K | +20% | $0 |
| M | 2025-08-13 | 2025-04-28+ | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | -250.4K | 3.30M | -7% | $0 |
| I | 2025-08-13 | 2025-08-11 | OCUL | Dugel Pravin | See Remarks, Dir | G - Gift | $0.00 | +250.4K | 250.4K | New | $0 |
| D | 2025-06-13 | 2025-06-11 | OCUL | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +14.0K | 143.1K | +11% | $0 |
| D | 2025-06-13 | 2025-06-11 | OCUL | Hong Seung Suh | Dir | A - Grant | $0.00 | +14.0K | 46.9K | +43% | $0 |
| D | 2025-06-13 | 2025-06-11 | OCUL | RAINES MERILEE | Dir | A - Grant | $0.00 | +14.0K | 46.9K | +43% | $0 |
| D | 2025-06-13 | 2025-06-11 | OCUL | Graves Adrienne L | Dir | A - Grant | $0.00 | +14.0K | 50.0K | +39% | $0 |
| D | 2025-06-13 | 2025-06-11 | OCUL | Williams Leslie J. | Dir | A - Grant | $0.00 | +14.0K | 51.4K | +37% | $0 |
| D | 2025-06-13 | 2025-06-11 | OCUL | Warden Charles M | Dir | A - Grant | $0.00 | +14.0K | 86.5K | +19% | $0 |
| 2025-06-03 | 2025-06-02 | OCUL | Waheed Nadia | Chief Medical Off | S - Sale | $8.05 | -13.9K | 206.8K | -6% | -$111.6K | |
| 2025-05-27 | 2025-05-23 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $7.18 | -21.2K | 3.50M | -0.6% | -$152.4K | |
| 2025-05-27 | 2025-05-23 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $7.17 | -2,974 | 207.1K | -1% | -$21.3K | |
| 2025-05-27 | 2025-05-23 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $7.18 | -3,024 | 263.0K | -1% | -$21.7K | |
| 2025-05-27 | 2025-05-23 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $7.17 | -1,862 | 281.6K | -0.7% | -$13.4K | |
| 2025-05-12 | 2025-05-08 | OCUL | LINDSTROM RICHARD L MD | Dir | P - Purchase | $6.96 | +10.0K | 172.7K | +6% | +$69.6K | |
| 2025-02-26 | 2025-02-24 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $6.87 | -3,061 | 266.0K | -1% | -$21.0K | |
| 2025-02-26 | 2025-02-24 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $6.87 | -21.5K | 3.52M | -0.6% | -$147.5K | |
| 2025-02-26 | 2025-02-24 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $6.87 | -3,009 | 210.1K | -1% | -$20.7K | |
| 2025-02-26 | 2025-02-24 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $6.84 | -1,895 | 283.5K | -0.7% | -$13.0K | |
| D | 2025-02-13 | 2025-02-11 | OCUL | Nayak Sanjay | Chief Strategy Off | A - Grant | $0.00 | +111.0K | 285.4K | +64% | $0 |
| D | 2025-02-13 | 2025-02-11 | OCUL | Notman Donald | See Remarks | A - Grant | $0.00 | +115.0K | 308.4K | +59% | $0 |
| M | 2025-02-13 | 2025-02-11 | OCUL | Dugel Pravin | See Remarks, Dir | A - Grant | $0.00 | +2.75M | 2.04M | New | $0 |
| D | 2025-02-13 | 2025-02-11 | OCUL | Waheed Nadia | Chief Medical Off | A - Grant | $0.00 | +79.0K | 220.7K | +56% | $0 |
| M | 2025-02-04 | 2025-01-31+ | OCUL | Notman Donald | See Remarks | S - Sale | $7.82 | -17.4K | 204.6K | -8% | -$136.2K |
| 2024-11-27 | 2024-11-25 | OCUL | Heier Jeffrey S. | CSO | S - Sale | $9.01 | -2,948 | 269.1K | -1% | -$26.6K | |
| 2024-11-27 | 2024-11-25 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $9.00 | -1,814 | 174.4K | -1% | -$16.3K | |
| 2024-11-27 | 2024-11-25 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $9.01 | -20.7K | 791.8K | -3% | -$186.3K | |
| 2024-11-27 | 2024-11-25 | OCUL | Kaiser Peter | Chief Development Off | S - Sale | $9.01 | -2,897 | 213.1K | -1% | -$26.1K | |
| D | 2024-10-09 | 2024-10-07 | OCUL | Anderman Todd | CLO | A - Grant | $0.00 | +98.7K | 98.7K | New | $0 |
| D | 2024-10-04 | 2024-10-02 | OCUL | Kaiser Peter | Chief Development Off | A - Grant | $0.00 | +100.0K | 216.0K | +86% | $0 |
| D | 2024-10-04 | 2024-10-02 | OCUL | Heier Jeffrey S. | CSO | A - Grant | $0.00 | +100.0K | 272.0K | +58% | $0 |
| D | 2024-09-03 | 2024-08-29 | OCUL | Notman Donald | See Remarks | A - Grant | $0.00 | +11.0K | 209.0K | +6% | $0 |
| 2024-08-27 | 2024-08-23 | OCUL | Nayak Sanjay | Chief Strategy Off | S - Sale | $9.02 | -1,832 | 176.2K | -1% | -$16.5K | |
| 2024-08-27 | 2024-08-23 | OCUL | Dugel Pravin | See Remarks, Dir | S - Sale | $9.02 | -20.9K | 812.5K | -3% | -$188.3K | |
| D | 2024-07-26 | 2024-07-24 | OCUL | Graves Adrienne L | Dir | A - Grant | $0.00 | +12.0K | 36.0K | +50% | $0 |
| D | 2024-07-26 | 2024-07-24 | OCUL | Williams Leslie J. | Dir | A - Grant | $0.00 | +12.0K | 37.4K | +47% | $0 |
| DM | 2024-07-26 | 2024-02-27 | OCUL | LINDSTROM RICHARD L MD | Dir | M - OptEx | $8.80 | +30.3K | 150.7K | +25% | +$266.7K |
| D | 2024-07-26 | 2024-07-24 | OCUL | LINDSTROM RICHARD L MD | Dir | A - Grant | $0.00 | +12.0K | 162.7K | +8% | $0 |
| D | 2024-07-26 | 2024-07-24 | OCUL | RAINES MERILEE | Dir | A - Grant | $0.00 | +12.0K | 32.9K | +57% | $0 |
| D | 2024-07-26 | 2024-07-24 | OCUL | Warden Charles M | Dir | A - Grant | $0.00 | +12.0K | 72.5K | +20% | $0 |
| D | 2024-07-26 | 2024-07-24 | OCUL | Hong Seung Suh | Dir | A - Grant | $0.00 | +12.0K | 32.9K | +57% | $0 |
Purchase Sale Sale after option exercise All abbreviations